Insights

Strategic Partnerships Position Xsphera as a preferred collaborator for pharma and leading cancer centers to leverage the ex vivo human-tissue platform, with proven collaboration as a validation of capability and scale.

Platform as SaaS Market the cloud-based platform as an integrated solution for data ingestion, multi-omics integration, and AI-driven analytics, enabling partners to consolidate tissue, patient, and results data into a single source to accelerate decision making.

Indication Expansion Show capability to assess therapeutic efficacy across multiple cancer indications and drug modalities, enabling partners to broaden pipelines and de-risk asset progression.

Enterprise Security Highlight enterprise-grade security, data governance, and regulatory compliance to reassure large pharmaceutical clients about data privacy and cross-border trial requirements.

Ex Vivo Advantage Differentiate from traditional in vivo models by providing human-tissue based predictions of human response, accelerating insights and potentially reducing clinical failure rates.

Xsphera Biosciences Inc Tech Stack

Xsphera Biosciences Inc uses 8 technology products and services including Amazon Web Services, oEmbed, Microsoft Online, and more. Explore Xsphera Biosciences Inc's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • oEmbed
    Dev Tools
  • Microsoft Online
    Email Hosting
  • HubSpot
    Marketing Automation
  • PHP
    Programming Languages
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics
  • Apache HTTP Server
    Web Servers

Xsphera Biosciences Inc's Email Address Formats

Xsphera Biosciences Inc uses at least 1 format(s):
Xsphera Biosciences Inc Email FormatsExamplePercentage
First@xspherabio.comJohn@xspherabio.com
97%
First.Last@xspherabio.comJohn.Doe@xspherabio.com
3%

Frequently Asked Questions

What is Xsphera Biosciences Inc's official website and social media links?

Minus sign iconPlus sign icon
Xsphera Biosciences Inc's official website is xspherabio.com and has social profiles on LinkedInCrunchbase.

What is Xsphera Biosciences Inc's SIC code NAICS code?

Minus sign iconPlus sign icon
Xsphera Biosciences Inc's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Xsphera Biosciences Inc have currently?

Minus sign iconPlus sign icon
As of July 2026, Xsphera Biosciences Inc has approximately 16 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Member: S. R.. Explore Xsphera Biosciences Inc's employee directory with LeadIQ.

What industry does Xsphera Biosciences Inc belong to?

Minus sign iconPlus sign icon
Xsphera Biosciences Inc operates in the Biotechnology Research industry.

What technology does Xsphera Biosciences Inc use?

Minus sign iconPlus sign icon
Xsphera Biosciences Inc's tech stack includes Amazon Web ServicesoEmbedMicrosoft OnlineHubSpotPHPBootstrapGoogle AnalyticsApache HTTP Server.

What is Xsphera Biosciences Inc's email format?

Minus sign iconPlus sign icon
Xsphera Biosciences Inc's email format typically follows the pattern of First@xspherabio.com. Find more Xsphera Biosciences Inc email formats with LeadIQ.

How much funding has Xsphera Biosciences Inc raised to date?

Minus sign iconPlus sign icon
As of July 2026, Xsphera Biosciences Inc has raised $18M in funding. The last funding round occurred on May 02, 2023 for $13M.

When was Xsphera Biosciences Inc founded?

Minus sign iconPlus sign icon
Xsphera Biosciences Inc was founded in 2018.
Xsphera Biosciences Inc logo

Xsphera Biosciences Inc

Biotechnology ResearchMassachusetts, United States11-50 Employees

Xsphera Biosciences Inc. is a biotechnology research company based in Cambridge, Massachusetts. It has developed an ex vivo platform that uses human tumor tissue to evaluate responses to cancer therapies in controlled conditions, aiming to improve the predictive relevance of preclinical testing for human patients. The approach seeks to capture the tumor microenvironment and measure how different treatments influence tumor cells and immune activity within a clinical context.

The platform brings together tissue, patient, and result data in a single cloud-based system, where AI-assisted analysis interprets complex multi-omic response data to generate actionable insights. Its primary customers are oncology drug developers and clinical teams seeking to de-risk programs and deepen understanding of why therapies succeed or fail. In a recent development, the company announced a collaboration with Dana-Farber Cancer Institute to advance its platform using fresh human tumor tissue to assess therapeutic efficacy across cancer indications.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $18M

    Xsphera Biosciences Inc has raised a total of $18M of funding over 2 rounds. Their latest funding round was raised on May 02, 2023 in the amount of $13Mas a series_a.

  • $10M$25M

    Xsphera Biosciences Inc's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $18M

    Xsphera Biosciences Inc has raised a total of $18M of funding over 2 rounds. Their latest funding round was raised on May 02, 2023 in the amount of $13Mas a series_a.

  • $10M$25M

    Xsphera Biosciences Inc's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.